Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years
Sponsor: Sanofi Pasteur, a Sanofi Company
Summary
This multi-center, prospective, longitudinal cohort study is designed to gather immunological and clinical data on EBV reactivation in EBV seropositive adults aged 18 to 29 years. This study will follow a cohort of approximately 100 EBV seropositive adults 18 to 29 years of age in Australia over a 6 or 12-month period. Participants will not receive any study intervention (eg, study treatments, vaccines).
Official title: A Multi-center, Prospective, Longitudinal Cohort Study to Collect Immunological and Clinical Data on Epstein-Barr Virus (EBV) Reactivation in EBV Seropositive Male and Female Adults Aged 18 to 29 Years
Key Details
Gender
All
Age Range
18 Years - 29 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2026-04-20
Completion Date
2027-05-19
Last Updated
2026-04-17
Healthy Volunteers
Yes
Interventions
Investigational Procedure
It consists of prospective blood and saliva collections. Study without any IMP administration.